Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
NeuropathyAIDS
Interventions
DRUG

dimiracetam

400 mg capsules for oral use to be administered twice a day for a total of 8 weeks

DRUG

sugar pill

capsules containing 400 mg of inert material will be orally administered twice a day, one pill for 2 weeks, 2 pills for other 2 weeks and 4 pills for the last 4 weeks.

Trial Locations (1)

6001

Aurora Hospital Triple Research, Port Elizabeth

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cross Research S.A.

INDUSTRY

collaborator

Triclinium clinical trial project managment LTD

UNKNOWN

lead

Neurotune AG

INDUSTRY